These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9524654)

  • 1. [The current and future outlook in immunosuppressive therapy for children].
    Goţia S; Ionescu C
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):35-42. PubMed ID: 9524654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic prospects in autoimmunity].
    Revillard JP
    Rev Prat; 1994 Jan; 44(1):93-7. PubMed ID: 8178066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune dermatoses: new therapeutic strategies].
    Trüeb RM
    Praxis (Bern 1994); 2000 Sep; 89(37):1460-7. PubMed ID: 11037617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The current outlook in the therapy of autoimmune diseases].
    Sebastiani GD; Passiu G
    Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy in non-allergic diseases].
    Español T
    Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
    Wolfraim LA
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs in autoimmune diseases.
    Herrmann DB; Bicker U
    Klin Wochenschr; 1990; 68 Suppl 21():15-25. PubMed ID: 2198387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell targeted therapies in autoimmune diseases.
    Isenberg DA
    J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective immunosuppression.
    Adorini L; Guéry JC; Rodriguez-Tarduchy G; Trembleau S
    Immunol Today; 1993 Jun; 14(6):285-9. PubMed ID: 8104410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New methods of therapy for ocular inflammatory autoimmune diseases].
    Kubicka-Trzaska A; Undas A
    Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution and future of immunosuppression in renal transplantation.
    Goral S; Helderman JH
    Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutics of multiple sclerosis.
    Durelli L
    Acta Neurol (Napoli); 1991 Oct; 13(5):467-75. PubMed ID: 1723242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel therapies for MG: Studies in animal models.
    Souroujon MC; Brenner T; Fuchs S
    Autoimmunity; 2010 Aug; 43(5-6):446-60. PubMed ID: 20298126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy of autoimmune diseases.
    Bach JF
    Immunol Today; 1993 Jun; 14(6):322-6. PubMed ID: 8104411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present and future of immunosuppressive therapy].
    Eugui EM
    Medicina (B Aires); 2000; 60(1):67-80. PubMed ID: 10835702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokines and autoimmunity].
    Emilie D; Galanaud P
    Rev Prat; 1994 Jan; 44(1):28-31. PubMed ID: 8178054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of monoclonal antibodies to achieve immunological tolerance.
    Waldmann H; Cobbold S
    Immunol Today; 1993 Jun; 14(6):247-51. PubMed ID: 8397765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune therapies of autoimmune diseases: are we approaching a real cure?
    Chatenoud L
    Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.